Immunoglobulin activation of T cell chemoattractant expression in fibroblasts from patients with Graves' disease is mediated through the insulin-like growth factor I receptor pathway

J Immunol. 2003 Jun 15;170(12):6348-54. doi: 10.4049/jimmunol.170.12.6348.

Abstract

Graves' disease (GD) is associated with T cell infiltration, but the mechanism for lymphocyte trafficking has remained uncertain. We reported previously that fibroblasts from patients with GD express IL-16, a CD4-specific chemoattractant, and RANTES, a C-C chemokine, in response to GD-specific IgG (GD-IgG). We unexpectedly found that these responses result from a functional interaction between GD-IgG and the insulin-like growth factor (IGF)-I receptor (IGF-IR). IGF-I and the IGF-IR-specific IGF-I analog, des(1-3), mimic the effects of GD-IgG. Neither GD-IgG nor IGF-I activates chemoattractant expression in control fibroblasts from donors without GD. Interrupting IGF-IR function with specific receptor-blocking Abs or by transiently transfecting fibroblasts with a dominant negative mutant IGF-IR completely attenuates signaling provoked by GD-IgG. Moreover, GD-IgG displaces specific (125)I-labeled IGF-I binding to fibroblasts and attenuates IGF-IR detection by flow cytometry. These findings identify a novel disease mechanism involving a functional GD-IgG/IGF-IR bridge, which potentially explains T cell infiltration in GD. Interrupting this pathway may constitute a specific therapeutic strategy.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adjuvants, Immunologic / biosynthesis
  • Adjuvants, Immunologic / genetics
  • Adjuvants, Immunologic / metabolism
  • Adjuvants, Immunologic / physiology
  • Autoantigens / biosynthesis
  • Autoantigens / genetics
  • Autoantigens / metabolism
  • Autoantigens / physiology
  • Cell Movement / immunology
  • Cells, Cultured
  • Chemokine CCL5 / biosynthesis*
  • Chemokine CCL5 / physiology
  • Chemotaxis, Leukocyte / genetics
  • Chemotaxis, Leukocyte / immunology
  • Fibroblasts / immunology*
  • Fibroblasts / metabolism
  • Fibroblasts / pathology
  • Graves Disease / immunology*
  • Graves Disease / pathology
  • Humans
  • Immunoglobulin G / metabolism
  • Immunoglobulin G / pharmacology*
  • Interleukin-16 / biosynthesis*
  • Interleukin-16 / physiology
  • Iodine Radioisotopes / metabolism
  • Protein Binding / immunology
  • Receptor, IGF Type 1 / biosynthesis
  • Receptor, IGF Type 1 / genetics
  • Receptor, IGF Type 1 / metabolism
  • Receptor, IGF Type 1 / physiology*
  • Signal Transduction / immunology*
  • T-Lymphocytes / cytology
  • T-Lymphocytes / immunology*
  • Transfection

Substances

  • Adjuvants, Immunologic
  • Autoantigens
  • Chemokine CCL5
  • Immunoglobulin G
  • Interleukin-16
  • Iodine Radioisotopes
  • Receptor, IGF Type 1